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Summary.-The radiation technique described is an unconventional method of
treatment for carcinoma cervix patients and is essentially external beam therapy
alone, using a 60Cobalt rotation plan. This is in contrast to the more conventional
series of 2 or 3 intracavitary radium insertions, either preceded and/or followed by
fixed field external beam therapy. An advantage to the patient from this treatment
scheme is the avoidance of the trauma associated with the repeated anaesthetics
required for uterine and vaginal radium applications. Dosage levels have also
been determined to ensure minimal post-radiation complications, and the 5- and
10-year survival rates for stage II and stage III cases are comparable with the
survival results published by other centres. The series was treated during 1957-64
and consisted of all stage II and III cases referred to the Westminster Radiotherapy
Department during this period, together with 13 stage I cases which were considered
to be poor anaesthetic risks, and 4 stage IV cases. The 5- and 10-year survival
rates for 69 stage II cases were 44% and 36% respectively, and for 81 stage III cases
were 38% and 23% respectively.
IT is good general practice in radio-
therapy to encompass the entire tumour
volume in a homogeneous zone of irradia-
tion. With this in view, Mellor (1960),
in collaboration with her colleagues at
Westminster Hospital, devised a method
using external irradiation with 60Cobalt,
employing two centres of rotations and
two 160° arcs to treat carcinoma of the
cervix. The field size used was 8 cm x 15
cm. Typical isodose curves are repro-
duced in Fig. 1. Studies at that time
showed that the posterior part of the
bladder and part of the rectum were
included within the 80% isodose curve.
Her experience was confined to 17 patients
and the opportunity is now taken of
giving an account ofpatients subsequently
treated, essentially in a similar manner.
MATERIAL AND METHODS
A total of 179 patients were treated using
the rotation technique between the years
1957 and 1964, and their stage distribution
is given in Table I. It should be emphasized
that not all these patients were staged by
the same clinicians but at least two clinicians,
usually a gynaecologist and a radiotherapist,
were responsible for the assessment.
TABLE I.-Stage Distribution
Stage No. of cases
I 13
II 73
III 89
IV 4
All stages 179
It was only with some reluctance that
Stage I cases were included, in view of the
many reported excellent results of con-
ventional intracavitary methods supple-
mented by pelvic side wall irradiation.
However, 13 patients, most of whom were
considered poor anaesthetic risks, were
treated by this method in spite of their
early stage. Selection of patients for theTREATMENT OF CARCINOMA OF THE CERVIX
FIG. 1. Rotational technique isodose distribution.
series was therefore usually limited to stage
II and III only.
TABLE II. Histology Distribution
Histology
Squamous
Adenocarcinoma
" Carcinoma " no further (letails
No record of biopsy
No. of cases
136
16
16
11
One hundred and sixty-eight patients
under study have had histological confirma-
tion of their disease (Table II). The group
of 16 patients classified as " carcinoma "
were referred from elsewhere and, although
there was written confirmation of histologic-
ally proven cancer, we were unable to
obtain the original sections for classification.
The correlation of stages II and III cases
with proven histology is shown in Table III
and the age distribution is shown in Table
IV. Of the 162 stage II and III cases in
Table I, 10 were omitted due to no proven
carcinoma and 2 were omitted since they
were lost to follow-up immediately after the
completion of treatment.
Since this report is a retrospective study,
no attempt has been made to classify stage
II tumours into Groups A and B. No
patient with stage 0 (carcinoma in situ) was
included.
Treatment method
With the early use of the technique it
became apparent that it was important to
limit the dose, as it was evident that the
frequency of complications was strictly dose
related (Newton, 1964). It therefore became
general practice to limit the dose to 5400 rad
on the 80% isodose curve at a rate of 200 rad
daily for 5 days per week, and this has
resulted in a minimal complication rate.
The treatment was modified in the later
cases which were assessed at 2-4 weeks after
completion of external radiotherapy, and
at this time a single uterine radium tube
(50 mg) was inserted for 36-48 hours as an
additive measure. Although this procedure
resulted in some additional radiation to the
bladder and rectum, it did not raise the
incidence of complications. For some cases
no radium was inserted, and this was usually
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TABLE III.-Distribution byStage and
Histology
Histology
Disease
stage
II
III
Squamous
cell
carcinoma
55
66
Adeno-
carcinoma
7
8
Carcinoma
-no
further
details
7
7
Total
cases
69
81
due either to an inability to dilate the
cervical canal or to the fact that the referring
gynaecologist was satisfied with the initial
response and did not send the patient for
follow-up assessment. A total of 43 cases
were treated with the single uterine source.
Since the numbers of patients involved
were small, it was not considered practical
to assess survival rates by stage, for treat-
ment with and without the uterine radium.
TABLE IV.-Distribution by Stage and Age
Age range
(years)
20-29
30-39
40-49
50-59
60-69
70-79
80-89
Total
Stage II
1
7
13
22
18
6
2
Stage III
0
7
15
18
28
13
0
69 81
DISCUSSION
In a relatively unconventional method,
i.e. treatment principally by external
radiation compared with more conven-
tional and long established intracavitary
radium with or without pelvic side wall
irradiation, it is pertinent to compare
firstly the relative advantages of the two
methods and secondly, and perhaps of
more importance, the survival results.
1. Practical advantages of the method
Homogeneity of irradiation has been
achieved by others, with varying degrees
of success, by careful planning and use
of specially shaped 'wedged fields to
marry with the intracavitary radiation
distribution (Newall and Sischy, 1970).
This total dosage homogeneity consists of
two sharply differing time schedules and
in other situations in the body is not
considered the method of choice. The
isodose curves achieved by our method
embrace the entire cervix and parame-
trium as far as the pelvic side wall at a
shallow dosage gradient from 80% to
100%. It is unlikely, therefore, that
any tumour tissue would receive less
than 5400 rad in 51 weeks, the exceptions
being extensive bladder or rectal involve-
ment and spread to lower para-aortic
nodes, i.e. a proportion of the more
advanced cases.
It has therefore been possible to
arrive at a radiation dose level in which
complications have an acceptably low
rate and are lacking in severity. This
dose level is 5400 rad from external
beam therapy, with additional radiation
from a single uterine source 2-4 weeks
after completion of the primary external
beam treatment.
From the point of view of the patient,
it is clearly advantageous to avoid the
repeated anaesthetics necessary for mul-
tiple intracavitary insertions and to have
as short an overall treatment time as
possible. Only the Cathetron after-load-
ing technique can compete favourably in
the minimalradiationexposure toinvolved
staff.
2. Survival results
For the 150 stage II and III cases*
treated during 1957-64, a follow-up ana-
lysis was made in 1972-73, when all
patients had been at risk for at least 8
years. Follow-up data for at least 5
years has been obtained for all 150 cases,
but some have been lost to subsequent
follow-up. This is seen in Fig. 2, which
is a dot diagram representing the patient
* Of the original 179 cases in the series, the following 29 cases have been omitted from the forgoing
analysis: 13 stage I cases, of which 7 were alive at 5 years subsequent to treatment; 4 stage IV cases;
10 stage II and III cases with no proven biopsy; 2 stage II and III cases which were lost to follow-up
immediately subsequent to treatment.
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FIG. 2.-Dot diagram for the series of 150 carcinoma cervix cases.
condition at last follow-up of all 150
patients. The circles represent those who
have died and the triangles those patients
who are still alive, and it is seen that all
the triangles are to the right of the
5-year vertical boundary. This repre-
sents a very good follow-up on the series.
Survival rates between one and 10
years subsequent to treatment have been
calculated for the two stage groups, using
the actuarial or life table method which
has been described in detail by Cutler
and Ederer (1958). The advantage of
the actuarial method is that it makes
possible the use of all survival information
accumulated to the end of the period of
observation. This is in contrast to the
direct method of calculating a T-year
rate, when all patients must have been
at risk for at least T years before calcula-
tion of the rate.
Fig. 3 shows the survival rates for
the two disease stages for all causes of
death, and the vertical bars represent
one standard error. From this graph
it is seen that the T-year survival rate
for stage II is always some 10% higher
than the rate for stage III. Due to the
small sample sizes, however, this per-
centage difference is not significant at
the 0 05 level.
An analysis of 40 recent publications
of survival results of carcinoma cervix
treatments has shown that T-year survival
rates are still usually calculated by a
direct method, with varying assumptions
made about the fate of those patients
lost to follow-up before they have been
at risk for at least T years (Mould, 1973).
Also, the disease stages of series found in
the literature are not always according
to the definitions of Kottmeier (1967),
the treatment schemes are multiple and
often include some surgery, and the
series may represent either a selected
group, as in this paper, or the total
case load at the given hospital. It is
therefore difficult to draw any detailed
conclusions from a comparison of the
5- and 10-year survival rates of our
series and those quoted in the literature.
The data from other centres, Table V,
has been taken from the report by
Kottmeier (1967) covering results of'
patients treated in 1951-60. The " rela-
tive apparent recovery rates at the end
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STA 11 CARCINOMA CERVIX
69 CASES
STAGE III CARCINOMA CERVIX
81 CASES
1 2 3 4 5 6
SURVIVAL TI ME (YEARS)
7
FIG. 3. Survival rates (actuarial calculation) for stages II and III carcinoma cervix.
TABLE V.-Comparison between the Selected Westminster " Theratron " Series and
Results Comprising the Total Patient Experience from Other Centres
Relative apparent recovery rate at the end of T years,
Kottmeier (1967)*
Stage II
I& A
Centre
Birmingham
Bristol
Cambridge
Cardiff
Coventry
Edinburgh
Glasgow
Liverpool
Marie Curie
Middlesex
Royal Marsden
U.C.H.
Manchester
Newcastle
Northwood
Sheffield
Southampton
Westminster " Thera-
tron " Series
No. of cases
1956-60 1951-55 T=5
422 454 0-424
112 84 0 455
120 86 0 450
237 160 0 422
37 42 0 405
191 177 0-445
195 182 0 426
399 309 0-471
155 150 0-361
77 77 0 532
125 149 0 424
49 46 0 408
942 885 0-466
111 - 0-486
128 104 0-367
188 210 0 468
132 108 0-424
69 cases 0-435
1957-64 ±0 060
T=10
0 297
0 345
0-384
0-269
0 310
0-243
0- 313
0 343
0 247
0 234
0-369
0- 326
0-364
0-375
0 367
0-380
0-361
±0-058
Stage III
No. of cases
1956-60 1951-55 T=5 T=10
266 160 0-218 0-119
96 50 0-115 0-080
55 48 0-291 0 250
103 99 0-252 0-121
44 27 0 273 0 074
128 136 0.227 0 066
113 121 0-301 0-083
326 279 0-325 0 262
48 58 0 208 0-103
44 33 0 250 0-152
75 81 0-147 0 123
25 33 0 240 0-121
506 400 0-263 0-218
50 0 260
139 57 0-151 0-158
181 207 0 309 0-193
75 89 0-240 0-124
81 cases 0-383 0-233
1957-64 ±0-054 ±0-049
* The 5-year rates are for cases treated 1956-60 and the 10-year rates for cases treated 1951-55.
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of T-years " given in this report represent
a direct calculation of the quotient:
(Number alive with no evidence of the
disease after a period of observation
of T-years)
(Total number of patients treated)
This is the fraction surviving to
T-years subsequent to treatment when
all causes of death are considered, and
the cases lost to follow-up are assumed
to have died before T-years have elapsed.
Ifthe proportion of cases lost to follow-up
is greater than 2% of the total series,
this method of calculation may under-
estimate the " actuarial " survival rate
by at least some 5%. It must also be
noted that the Stockholm Report results
are only an average for a variety of
treatment policies at the centres con-
cerned. However, the treatments were
usually the established intracavitary irra-
diation (with variations in vaginal colpo-
stat design, radium loading and fractiona-
tion) plus pelvic side wall irradiation.
Although our patient numbers are small,
the survival results (Table VI) certainly
appear to be comparable with those of
the other centres, with the advantage of
less trauma to the patient, and the
TABLE VI.-Results
Stage II Stage III
No. of 5-year 10-year No. of 5-year 10-year
cases survival survival cases survival survival
69 44% 36% 81 38% 23%
knowledge that post-radiation complica-
tions are minimal.
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